FDA Approves Wegovy Pill for Weight Loss | Novo Nordisk’s Oral GLP-1 Breakthrough
FDA Approves Wegovy Pill: A New Era for Oral GLP-1 Weight Loss Medications Summary : FDA Approval: The FDA has approved the first-ever oral version of Wegovy, Novo Nordisk’s weight-loss drug, which contains semaglutide, the same active ingredient in Wegovy and Ozempic. Pill vs. Injection: This new pill version of Wegovy provides an alternative to […]
FDA Approves Wegovy Pill for Weight Loss | Novo Nordisk’s Oral GLP-1 Breakthrough Read More »